Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein–ligand recognition process
出版年份 2020 全文链接
标题
Prospects of
multitarget
drug designing strategies by linking molecular docking and molecular dynamics to explore the
protein–ligand
recognition process
作者
关键词
-
出版物
DRUG DEVELOPMENT RESEARCH
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-04-24
DOI
10.1002/ddr.21673
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Novel Promising 4-Anilinoquinazoline-Based Derivatives as Multi-target RTKs Inhibitors: Design, Molecular Docking, Synthesis, and Antitumor Activities in Vitro and Vivo
- (2019) Peng Xu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Ginkgolic Acid is a Multi-Target Inhibitor of Key Enzymes in Pro-Inflammatory Lipid Mediator Biosynthesis
- (2019) Jana Gerstmeier et al. Frontiers in Pharmacology
- Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview
- (2018) Veronica Salmaso et al. Frontiers in Pharmacology
- Computational Multitarget Drug Design
- (2017) Weilin Zhang et al. Journal of Chemical Information and Modeling
- Monte Carlo replica-exchange based ensemble docking of protein conformations
- (2017) Zhe Zhang et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Multitarget Drug Discovery and Polypharmacology
- (2016) Maria Laura Bolognesi et al. ChemMedChem
- In silico methods to address polypharmacology: current status, applications and future perspectives
- (2016) Antonio Lavecchia et al. DRUG DISCOVERY TODAY
- Deciphering the Complexity of Ligand–Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations
- (2016) Alberto Cuzzolin et al. Journal of Chemical Information and Modeling
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- A comprehensive map of molecular drug targets
- (2016) Rita Santos et al. NATURE REVIEWS DRUG DISCOVERY
- Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease
- (2016) Liang Zhang et al. Scientific Reports
- Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods
- (2015) Yung-Hao Wong et al. BMC Medical Genomics
- A New Method for Navigating Optimal Direction for Pulling Ligand from Binding Pocket: Application to Ranking Binding Affinity by Steered Molecular Dynamics
- (2015) Quan Van Vuong et al. Journal of Chemical Information and Modeling
- PSOVina: The hybrid particle swarm optimization algorithm for protein–ligand docking
- (2015) Marcus C. K. Ng et al. Journal of Bioinformatics and Computational Biology
- N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor
- (2014) Oscar M. Bautista-Aguilera et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Systems Biology Brings New Dimensions for Structure-Based Drug Design
- (2014) Jianfeng Pei et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models
- (2013) Kiyoshi Okamoto et al. CANCER LETTERS
- Protein-Ligand Docking in the New Millennium – A Retrospective of 10 Years in the Field
- (2013) S.F. Sousa et al. CURRENT MEDICINAL CHEMISTRY
- Polypharmacology in a Single Drug: Multitarget Drugs
- (2013) M. L. Bolognesi CURRENT MEDICINAL CHEMISTRY
- Shifting from the single to the multitarget paradigm in drug discovery
- (2013) José L. Medina-Franco et al. DRUG DISCOVERY TODAY
- Water Network Perturbation in Ligand Binding: Adenosine A2A Antagonists as a Case Study
- (2013) Andrea Bortolato et al. Journal of Chemical Information and Modeling
- Polypharmacology – Foe or Friend?
- (2013) Jens-Uwe Peters JOURNAL OF MEDICINAL CHEMISTRY
- Challenges and opportunities of drug repositioning
- (2013) Natalia Novac TRENDS IN PHARMACOLOGICAL SCIENCES
- Established and Emerging Trends in Computational Drug Discovery in the Structural Genomics Era
- (2012) Olivier Taboureau et al. CHEMISTRY & BIOLOGY
- Multi-Target Drugs: The Trend of Drug Research and Development
- (2012) Jin-Jian Lu et al. PLoS One
- Polypharmacology: drug discovery for the future
- (2012) A Srinivas Reddy et al. Expert Review of Clinical Pharmacology
- Molecular dynamics simulations and drug discovery
- (2011) Jacob D Durrant et al. BMC BIOLOGY
- The role of fragment-based and computational methods in polypharmacology
- (2011) Giovanni Bottegoni et al. DRUG DISCOVERY TODAY
- Integrating structure-based and ligand-based approaches for computational drug design
- (2011) Gregory L Wilson et al. Future Medicinal Chemistry
- The inevitable QSAR renaissance
- (2011) Richard D. Cramer JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil andN-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer’s Disease
- (2011) Irene Bolea et al. JOURNAL OF MEDICINAL CHEMISTRY
- From in silico target prediction to multi-target drug design: Current databases, methods and applications
- (2011) Alexios Koutsoukas et al. Journal of Proteomics
- A combination of cisplatin-eluting gelatin microspheres and flavopiridol enhances anti-tumour effects in a rabbit VX2 liver tumour model
- (2010) N Nitta et al. BRITISH JOURNAL OF RADIOLOGY
- Advances and Challenges in Protein-Ligand Docking
- (2010) Sheng-You Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Computer-Aided Identification ofTrypanosoma bruceiUridine Diphosphate Galactose 4′-Epimerase Inhibitors: Toward the Development of Novel Therapies for African Sleeping Sickness
- (2010) Jacob D. Durrant et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- In-Silico Approaches to Multi-target Drug Discovery
- (2010) Xiao Hua Ma et al. PHARMACEUTICAL RESEARCH
- Current combination chemotherapy regimens for metastatic breast cancer
- (2009) J. Schwartz AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
- (2009) G E Konecny et al. BRITISH JOURNAL OF CANCER
- Binding Estimation after Refinement, a New Automated Procedure for the Refinement and Rescoring of Docked Ligands in Virtual Screening
- (2009) Giulio Rastelli et al. Chemical Biology & Drug Design
- Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate
- (2009) Isao Fukuda et al. CHEMISTRY & BIOLOGY
- Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2009) E. Y. Yu et al. CLINICAL CANCER RESEARCH
- Prospect of a Dopamine Contribution in the Next Generation of Antidepressant Drugs: The Triple Reuptake Inhibitors
- (2009) Bruno Guiard et al. CURRENT DRUG TARGETS
- Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges
- (2009) Richard Morphy et al. CURRENT PHARMACEUTICAL DESIGN
- New Pharmacological Developments in the Treatment of Hepatocellular Cancer
- (2009) Niraj J. Gusani et al. DRUGS
- Targeting multiple kinases in glioblastoma multiforme
- (2009) Sith Sathornsumetee et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Imatinib treatment for gastrointestinal stromal tumour (GIST)
- (2009) Lisandro F. Lopes et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Empirical Scoring Functions for Advanced Protein−Ligand Docking with PLANTS
- (2009) Oliver Korb et al. Journal of Chemical Information and Modeling
- Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies
- (2009) Chiung-Ing Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia
- (2009) Jorge E. Cortes et al. JOURNAL OF CLINICAL ONCOLOGY
- CHARMM: The biomolecular simulation program
- (2009) B. R. Brooks et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Scoring ligand similarity in structure-based virtual screening
- (2009) Maria I. Zavodszky et al. JOURNAL OF MOLECULAR RECOGNITION
- A Phase II Study of Flavopiridol (Alvocidib) in Combination with Docetaxel in Refractory, Metastatic Pancreatic Cancer
- (2009) Richard D. Carvajal et al. PANCREATOLOGY
- Ligand binding to proteins: The binding landscape model
- (2009) David W. Miller et al. PROTEIN SCIENCE
- Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells
- (2008) E. Weisberg et al. BLOOD
- How many modes of action should an antibiotic have?
- (2008) H BROTZOESTERHELT et al. CURRENT OPINION IN PHARMACOLOGY
- Early Clinical Studies of Novel Therapies for Thyroid Cancers
- (2008) Steven I. Sherman ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma
- (2008) Guru Sonpavde et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
- (2008) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel paradigms for drug discovery: computational multitarget screening
- (2008) E JENWITHEESUK et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search